• 1Nong Jiu Shi Hospital, Xinjiang Army, Emin Xinjiang 834601; 2 Department of Neurology, Jiangyou People’s Hospital, Jiangyou Sichuan 621700; 3Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China;
Export PDF Favorites Scan Get Citation

目的:探讨普罗布考对动脉粥样硬化性脑梗死并高脂血症患者血脂及预后的影响。方法:将87例脑梗死并高脂血症患者随机分为两组,治疗组44例,对照组43例,两组除按动脉粥样硬化性脑梗死常规治疗外,停用一切降脂药物。治疗组给予普罗布考500mg bid/d。疗程为6个月。随访一年观察两组患者治疗后血脂水平及脑血管事件发生情况。结果:治疗组患者治疗前、后总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)间差异均有显著性意义(P lt;0.05)。两组患者治疗后各项血脂指标间差异均有显著性意义(P lt;0.05)。随访一年,显示治疗组患者心脑血管事件14次,对照组19次(P lt;0.05)。结论:普罗布考降脂疗效可靠、副作用轻微,降低心脑血管事件发生。可作为动脉粥样硬化性脑梗死并高脂血症患者的一、二级预防药物。

Citation: XIAO Weijun,ZHANG Hao,XU Pingrong.. Clinical Investigation on Treating Arteriosclerotic Cerebral Infarction Combined with Hyperlipemia by Prubucol. West China Medical Journal, 2009, 24(9): 2234-2236. doi: Copy